Human blood CD14 + monocytes are bone marrow-derived white blood cells that sense and respond to pathogens. Although innate immune activation by RNA viruses preferentially occurs through intracellular RIG-I-like receptors, other nucleic acid recognition receptors, such as Toll-like receptors (TLRs), play a role in finely programming the final outcome of virus infection. Here, we dissected how human monocytes respond to infection with either Coxsackie (CV), encephalomyocarditis (EMCV), influenza A (IAV), measles (MV), Sendai (SV), or vesicular stomatitis (VSV) virus. We found that in monocytes, type I interferon (IFN) and cytokine responses to infection were RNA virus specific and differentially involved TLR7 and TLR8, which sense single-stranded RNA. These TLRs activated distinct signaling cascades in monocytes, which correlated with differences in the production of cytokines involved in the polarization of CD4 + T helper cells. Furthermore, we found that TLR7 signaling specifically increased expression of the transcription factor FOSL1, which reduced IL-27 and TNF production by monocytes. TLR7, but not TLR8, activation of monocytes also stimulated Ca 2+ flux that prevented type I IFN responses. Our work demonstrates that in human monocytes, TLR7 and TLR8 triggered different signaling pathways that contribute to distinct phenotypes during RNA virus infection. In addition, we defined individual targets within these pathways that promoted specific T helper and antiviral responses.
INTRODUCTION
Human monocytes are bone marrow-derived leukocytes from the innate immune system with important functions in pathogen sensing and innate immunity during bacterial, viral, and fungal infections. Monocytes are broadly classified on the basis of the expression of CD14 and CD16 into classical (CD14 + ), intermediate (CD14 + CD16 + ), and nonclassical (CD14 low CD16 + ) monocytes (1, 2) . However, singlecell transcriptomic data suggests that monocytes are likely heterogeneous (3) . CD14 + classical monocytes are the most abundant population, representing 80 to 90% of circulating monocytes (4), and produce proinflammatory cytokines, phagocytose, and secrete reactive oxygen species after pathogen stimulation (2) .
During the course of a viral infection, circulating monocytes rapidly leave the bloodstream and migrate to tissues where, after pathogen sensing and/or other stimuli, they differentiate into macrophages or dendritic cells (DCs) (4) . This recruitment is essential for effective control, and ultimately, clearance of the infection. However, in addition to this function, monocytes can also exert direct antimicrobial responses and promote the adaptive immune response. Monocytes are equipped with pattern recognition and phagocytic receptors necessary for pathogen sensing and destruction, and they also produce proinflammatory cytokines, which may help initiate the adaptive immune response (4) .
Although peripheral blood monocytes are a major population targeted by viruses during host infection (5) (6) (7) (8) (9) , little is known about the early events that are triggered when RNA viruses interact with human monocytes and how these interactions modulate the phenotype and effector functions of the latter. Among the pattern recognition receptors expressed by monocytes, nucleic acid-sensing receptors are major components triggering cell activation during RNA virus infection (10) . Retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs), such as melanoma differentiation-associated protein 5 (MDA5), RIG-I, and DExH-box helicase 58 (DHX58 or LPG2), are cytoplasmic sensors of RNA (11) , whereas Toll-like receptor 7 (TLR7) and TLR8 are intracellular sensors located in endosomes that recognize singlestranded RNA. Both types of receptors induce the expression of proinflammatory cytokines and type I interferon (IFN) response upon RNA virus sensing (11, 12) . Monocytes from healthy individuals express RLRs (13) and both TLR7 (14) and TLR8 (15) , and their expression can vary in patients with infectious diseases as compared to healthy individuals (16, 17) .
In this study, we examined the signaling pathways downstream TLR7 and TLR8 that occur after monocyte infection with a panel of RNA viruses ex vivo and their capacity to drive specific cytokine production leading to the regulation of the adaptive immune response. We demonstrated that RNA virus infection induced a variety of phenotypes and distinct antiviral responses in human monocytes as a result of the simultaneous activation of various pattern recognition receptors. We focused on the role of TLR7 and TLR8 signaling, and we demonstrated that although both receptors recognize the same generic ligand, there were important differences between their activation. TLR7 preferentially promoted the expression of CD4 + T helper 17 (T H 17) cell polarizing cytokines after virus infection, whereas T H 1-type cytokine production and type I IFN response were dependent on TLR8 signaling. The differences in proinflammatory cytokine expression induced by TLR7 or TLR8 signaling were due to the TLR7-stimulated expression of Fos family member FOSL1, which inhibited type 1 cytokine expression. Furthermore, we uncovered a role for TLR7-dependent Ca 2+ flux in inhibiting type I IFN responses. Thus, TLR7 and TLR8 activation triggers different signaling pathways in human monocytes that contribute to their distinct functions during RNA virus infection.
Single-stranded RNA-sensing TLRs contribute to virus-specific monocyte functions
During infection of antigen-presenting cells (APCs), RNA viruses are first sensed by host cells through several pattern recognition receptors (30) , with a major contribution of those sensors that recognize viral nucleic acids (31) , and in particular, RLRs. Subsequently, nucleic acid-specific TLRs are also involved in fine tuning of the immune response after RLR innate activation (11) . We decided to examine the contribution of single-stranded RNA-sensing TLR (TLR7 and TLR8) to the cytokine patterns observed after infection of monocytes. TLR7 and TLR8 are both expressed by CD14 + monocytes ex vivo (fig. S1), and their abundance is increased after virus encounter (14, 32, 33) . To test their involvement in monocyte activation, we blocked each of them individually with inhibitory oligodeoxynucleotides specific for TLR7 (IRS661) (34) and TLR8 (IRS957) (35, 36) in human monocytes before infection with RNA viruses. When we examined monocyte proinflammatory cytokine gene expression by real-time polymerase chain reaction (PCR) and protein secretion by enzyme-linked immunosorbent assay (ELISA), we found that stimulation of monocytes with IRS661 or IRS957 alone did not have any effect on cytokine expression ( fig. S2 ). Both TLR7 and TLR8 blockade had virus-and cytokine-specific effects after infection ( Fig. 2 ). TLR8 blockade did not inhibit the expression of IL1B nor IL23A in monocytes during virus infection. In contrast, in those virus infections that induced T H 17-polarizing cytokines (IAV, MV, and VSV), TLR7 blockade statistically significantly decreased IL1B and IL23A expression while having no effect on EMCV, SV, and CV infections. The regulation of IL6 expression by TLR7 and TLR8 was virus specific, and although TLR7 blockade had no effect on IL6 expression upon CV, EMCV, SV, or VSV infections, it decreased IL6 expression in MV and IAV infections. Similarly, TLR8 blockade had no effect on IL6 expression triggered by all viruses except for EMCV, where it led to decreased gene expression ( Fig. 2A ). Blockade of both TLR7 and TLR8 by the simultaneous use of IRS661 and IRS957 did not completely abrogate cytokine expression, supporting the involvement of other pattern recognition receptors such as RLR, in innate immune cell activation after RNA infection ( fig. S3 ).
TLR7 and TLR8 had different effects on T H 1-polarizing cytokine expression. Whereas TLR7 blockade had no effect on the expression of IL12B, IL27, or TNF triggered by any virus, TLR8 blockade significantly decreased the expression of IL12B and IL27 in CV, EMCV, MV, and SV infections. TNF was also inhibited in EMCV and IAV infections in the presence of the TLR8 antagonist IRS957 ( Fig. 2A ). TLR7 and TLR8 silencing in monocytes and subsequent virus infection confirmed the results obtained with IRS661 and IRS957 antagonist oligonucleotides ( fig. S4 ). Cytokine secretion data assessed by ELISA supported the gene expression results and suggested that TLR7 was involved in the expression of T H 17-polarizing cytokines [interleukin-1 (IL-1), IL-6, and IL-23] after viral infection, whereas TLR8 promoted the expression of T H 1-type cytokines (IL-27 and TNF) and IL-6 ( Fig. 2B ).
TLR7 does not contribute to monocyte type I IFN response triggered by RNA viruses
We went on to examine the involvement of TLR7 and TLR8 signaling on the generation of a type I IFN response during virus infection. Monocytes were preincubated with IRS661 and IRS957 and infected with RNA viruses as above, and we determined the expression of IFNA1, IFNA2, and IFNB1 by real-time PCR (Fig. 3A) . Whereas TLR8 blockade statistically significantly inhibited the expression of these genes in most virus infections, TLR7 blockade had no effect. In some cases, such as EMCV infection, TLR7 blockade statistically significantly increased IFNA1, IFNA2, or IFNB1 expression. These results were confirmed at protein level by measuring IFN and IFN cytokines in the culture supernatant ( Fig. 3B ). Furthermore, the expression of the ISGs EIF2AK2, IFITM1, ISG15, MOV10, and TRIM5 was decreased by TLR8 blockade, whereas there was no effect after TLR7 blockade, with the exception of a slight reduction in IFITM1 and ISG15 expression after MV infection and EIF2AK2 and ISG15 after SV infection ( Fig. 3C ). TLR7 and TLR8 silencing further confirmed the absence of involvement of TLR7 in the type I IFN response after RNA virus infection and the role of TLR8 in triggering it ( fig. S5) . 
Monocyte TLR7 triggering promotes CD4 + T H 17 polarization, but TLR8 stimulation promotes T H 1 differentiation
The different effects of TLR7 and TLR8 inhibition on proinflammatory cytokine expression and type I IFN responses led us hypothesize that TLR7 and TLR8 stimulation induce different functional phenotypes on CD14 + monocytes. To test this hypothesis, we chose imiquimod (IMQ) as a human TLR7-specific ligand and ssRNA40-LyoVec (ssRNA40) as a human TLR8-specific ligand, and we stimulated ex vivo isolated CD14 + monocytes with them to examine the expression of proinflammatory cytokines ( Fig. 4 ). In agreement with the inhibition experiments, IMQ treatment induced the expression of IL1B, IL6, IL23A, and TGFB1 but failed to increase the expression of IL12B, IL18, IL27, or TNF. On the contrary, T H 1-type cytokine gene expression was statistically significantly increased after ssRNA40 stimulation. TLR8 triggering also increased the expression of IL6 and IL1B, albeit at lower levels as compared to TLR7 stimulation (Fig. 4A ). These differences were not due to a kinetics issue, because IMQ did not induce IL12B, IL27, or TNF expression at any time point examined during the 24 hours of stimulation ( fig. S6A ). Moreover, the differences in protein expression were not due to differences in cell numbers, as confirmed by flow cytometry (fig. S6 , B and C). To determine whether the distinct cytokine expression patterns by IMQ and ssRNA40 were due to the specific concentrations of IMQ or ssRNA40 used, we stimulated monocytes with various concentrations of each TLR ligand covering the concentration ranges recommended by the manufacturer. Supernatant from the cultures were used to determine IL-1, IL-6, IL-12, and TNF secretion by ELISA ( Fig. 4B ). Whereas TLR8 stimulation induced the secretion of all cytokines examined, IMQ-stimulated monocytes did not promote secretion of IL-12 at any concentration tested, and it only induced a detectable amount of TNF with the highest concentration used. The different cytokine production patterns were TLR7 and TLR8 specific, as TLR7 blockade with IRS661 inhibited IMQ-dependent secretion of IL-1 and IL-6, but not TNF, and had no effect on cytokines released by ssRNA40-stimulated monocytes. In contrast, TLR8 blockade with IRS957 significantly decreased the secretion of IL-6 and TNF but not IL-1 release upon ssRNA40 stimulation, while not affecting the production of IL-1 nor TNF, and increasing IL-6 secretion after IMQ stimulation ( Fig. 4C ).
To further confirm the specificity of our results, we stimulated monocytes with other human TLR7-and TLR8-specific ligands, 
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including gardiquimod (GDQ) and loxoribine (Loxo) as TLR7 ligands, and single-stranded RNA double-right (ssRNA-DR) and Poly(U) as TLR8-specific ligands. Gene expression analysis of T H 1-and T H 17type cytokines confirmed that TLR7 ligands preferentially induce IL1B, IL6, and IL23A, whereas TLR8 ligands increase the expression of IL12B, IL27, and TNF (Fig. 4D ), and this was confirmed at protein level in the culture supernatant ( fig. S6D ). Furthermore, we examined the expression of surface receptors and chemokines that have been associated to type 1 and 17 responses in monocytes. We found that TLR8 stimulation did not increase the expression of inducible T cell costimulator ligand (ICOSL), which is important for human T H 17 differentiation (37), but did increase the expression of the T H 1-related receptor CD40 (38) . In contrast, TLR7 signaling slightly increased the expression of ICOSL but did not induce CD40 expression at both the RNA and protein levels ( Fig. 4 , D to F). Moreover, IMQ-treated monocytes statistically significantly increased the expression of the chemokine CCL20, the ligand for CCR6, which is preferentially expressed by T H 17 cells (39) . In contrast, ssRNA40-stimulated monocytes increased CXCL10 expression, the ligand for the chemokine receptor CXCR3, which is preferentially expressed by T H 1 cells (40) .
To functionally confirm the capacity of TLR7-and TLR8-stimulated monocytes to induce T H 17 and T H 1 cells, respectively, we stimulated monocytes with IMQ, ssRNA40, or vehicle and subsequently cocultured them with CD4 + T cells isolated from the same donors in the presence of only anti-CD3, to allow monocytes to provide the costimulatory signals under a similar polyclonal TCR stimulation ( Fig. 5 ). Subsequently, CD4 + T cells were sorted by flow cytometry to examine the expression of T H 1-related (IFNG and TBX21), T H 2-related (IL4 and GATA3), T H 17-related (IL17A and RORC), and regulatory T cell (T reg )-related (FOXP3 and IL10) cytokines and transcription factors. CD4 + T cells that were cocultured with ssRNA40treated monocytes statistically significantly increased expression of IFNG and TBX21 and decreased expression of GATA3 and RORC when compared to CD4 + T cells cocultured with vehicle-treated monocytes. However, CD4 + T cells cocultured with IMQ-treated monocytes failed to induce IFNG or TBX21 but statistically significantly increased the expression of IL17A and RORC. No differences were observed in the expression of FOXP3 or IL10 by CD4 + T cells in any coculture ( Fig. 5A ). Cytokine release in the cocultures measured by ELISA confirmed that IFN was only detected in the cocultures with ssRNA40treated monocytes, and IL-17 was preferentially secreted in cocultures with IMQ-treated monocytes (Fig. 5B ). The lack of T H 1 cell induction by IMQ-treated monocytes was also confirmed at early and late time points during the coculture period ( fig. S6E ).
The B cell adapter for phosphatidylinositol 3-kinase (PI3K)dependent activation of PI3K (BCAP) signaling inhibits proinflammatory cytokine secretion after TLR stimulation in DCs (41) . To examine whether differential activation of the PI3K pathway during TLR7 or TLR8 signaling was responsible, at least in part, for the phenotypes that we observed in monocytes, we stimulated monocytes ex vivo with IMQ or ssRNA40 in the presence of two widely used PI3K inhibitors (LY294002 and wortmannin), and we assessed IL-12 and IL-6 secretion. PI3K inhibition did not alter the secretion of IL-6 after IMQ or ssRNA40 stimulation but did reduce IL-12 production by TLR8-stimulated monocytes. Inhibition of PI3K after IMQ stimulation did not increase IL-12 expression, which suggests that the PI3K pathway is not involved in inhibition of proinflammatory cytokines in TLR7-stimulated monocytes ( fig. S7 ).
TLR7 preferentially signals through mitogen-activated protein kinase and displays defective nuclear factor B activation
A common feature of most TLR signaling pathways is the activation of three major transcription factors, i.e., AP-1 and nuclear factor B (NFB), responsible for proinflammatory cytokine release, and interferon regulatory factor 3 (IRF3), involved in the antiviral type I IFN response (42) . We examined whether the differences in proinflammatory cytokine secretion patterns elicited by TLR7 and TLR8 stimulation were due to differences in their capacity to activate AP-1 and NFB. For this, we stimulated human CD14 + monocytes with IMQ and ssR-NA40, and we measured the expression of phosphorylated MKK3/6, MKK4/7, and MEK1/2 ( Fig. 6 ). Mitogen-activated protein kinase (MAPK) kinases (MKKs) and MAPK kinases (MEKs) belong to the MAPK family and are involved in the activation of p38, c-Jun N-terminal kinase (JNK), and extracellular signal-regulated kinase (ERK), whose phosphorylation leads to AP-1 activation and secretion of proinflammatory cytokines (43) . MKK3/6 and MKK4/7 were rapidly and comparably activated upon IMQ or ssRNA40 stimulation. However, there was a small but statistically significant increase in the phosphorylation of MEK1/2 after IMQ stimulation at 5 and 15 min that was not observed after ssRNA40 stimulation (Fig. 6, A and B ). Subsequently, we assessed the expression of phosphorylated p38 and ERK1/2 after IMQ or ssRNA40 activation. TLR7 induced an increase in pp38 at all time points examined except for 60 min, whereas TLR8 stimulation only induced a modest increase at 5 and 30 min. The differences in p38 phosphorylation between IMQ-and ssRNA40stimulated monocytes were statistically significant at all time points examined except for 60 min. Furthermore, whereas TLR8 failed to increase pERK1/2 expression when compared to vehicle-treated cells, TLR7-stimulated monocytes displayed a sharp increase in pERK1/2 expression 5 min after stimulation ( Fig. 6 , C and D). These data suggest that TLR7 signaling induces MAPK activation more effectively than TLR8 signaling, in agreement with the increased IL-1 and IL-23 production observed, which are in part activated by AP-1 (44, 45) .
We went on to examine NFB activation after TLR7 and TLR8 stimulation. NFB is a homo-or heterodimer of NFB or Rel proteins. In resting cells, NFB remains in the cytoplasm in an inactive state, complexed with the inhibitory protein inhibitor of nuclear factor B (IB). TLR triggering activates NFB by both phosphorylation of its subunits and ubiquitination-mediated proteasomal degradation of IB, which leads to NFB translocation to the nucleus (46, 47) . We assessed NFB activation by p65 subunit phosphorylation and IB degradation (Fig. 6 , E and F). p65 phosphorylation showed a statistically significantly different kinetics on TLR7-stimulated monocytes as compared to TLR8-stimulated monocytes. Whereas ssRNA40 induced a robust activation of p65 maintained during 60 min of activation, IMQ-stimulated monocytes displayed a modest p65 activation at 15 and 30 min that rapidly vanished. Significant differences in phospho-p65 were observed at 45 and 60 min after activation when comparing IMQ-versus ssRNA40-treated monocytes (Fig. 6F ). IB expression correlated with the differences in p65 phosphorylation. Thus, although ssRNA40 induced a statistically significant decrease in the expression of IB by 30 min of activation, this was almost absent in IMQ-treated monocytes, and there was only a statistically significant decrease in its expression at 60 min, supporting the observation that TLR7 stimulation fails to induce robust NFB activation, and consequently, the expression of the type 1 cytokines that are dependent on NFB function, such as TNF (48, 49) , IL-12 (50) , and IL-27 (51, 52) . (53) . AP-1 regulation occurs both transcriptionally and posttranslationally after exposure to several different stimuli (54), including TLR ligation (55) . We examined the expression of AP-1 subunits elicited by ssRNA40 and IMQ as compared to vehicle-treated monocytes. The expression of all JUN family genes was similarly increased by either IMQ or ssRNA40 when compared to control ( fig. S8A) ; however, there were statistically significant differences in the expression of ATF1, ATF2, FOSL1, and FOSL2. Monocytes stimulated with TLR7 increased expression of all four transcription factors as compared to vehicle-treated monocytes, whereas TLR8-stimulated cells decreased ATF1 and ATF2 and slightly increased FOSL2 expression when compared to vehicle-stimulated monocytes. ssRNA40 had no effect on FOSL1 expression ( Fig. 7A) .
Unlike the rest of the FOS family, FOSL1 and FOSL2 proteins lack transactivation domains and display weak transactivation potentials. Under certain circumstances, they even act as inhibitors of AP-1 activity by competing for binding to AP-1 sites or by dimerizing with JUN and forming "inactive" heterodimers (54, 56, 57) . On the basis of these observations and the fact that type 1 cytokines, which require AP-1 activation (51, (58) (59) (60) (61) (62) (63) (64) , were not produced after TLR7 signaling, we hypothesized that increased expression of FOSL1 and/ or FOSL2 inhibited type 1 cytokines. To test this, we silenced ATF1, ATF2, FOSL1, and FOSL2 on CD14 + monocytes (fig. S8B ), and we subsequently stimulated them with either vehicle or IMQ. Gene expression analysis demonstrated that ATF1, ATF2, and FOSL2 silencing significantly decreased the expression of IL1B and IL6 after TLR7 stimulation, which suggested that these transcription factors have redundant roles in the expression of type 17 cytokines ( fig. S8C ). IL23A expression was decreased in ATF2-silenced monocytes as compared to controls after IMQ treatment, which suggested that ATF2 promoted IL23A transcription. Genetic deletion of FOSL1 had no effect on any of the type 17 cytokines measured. However, when we examined the expression of type 1 cytokines (Fig. 7B ), FOSL1 silencing significantly increased the expression of IL12B, IL27, and TNF after IMQ treatment, as compared to nontarget (NT)-transfected cells. ATF1, ATF2, and FOSL2 silencing had no effect on type 1 cytokine expression after IMQ stimulation. We confirmed the inhibitory effects of FOSL1 on type 1 cytokine secretion by measuring IL-27 and TNF secretion in the culture supernatant from FOSL1-silenced monocytes (Fig. 7C) .
Because TLR7 and TLR8 displayed nonoverlapping roles in the secretion of specific cytokines after RNA virus infections ( Fig. 1) , we examined the expression of FOSL1 in monocytes stimulated with RNA viruses. We observed that FOSL1 expression was significantly increased after IAV, MV, and VSV infections as compared to vehicle-treated monocytes (Fig. 7D) , which displayed a more T H 17polarizing capacity that was partly TLR7 dependent ( Fig. 2) . To examine whether virus-induced FOSL1 regulates the expression of type 1 cytokines, we infected FOSL1-or NT-silenced monocytes with IAV, MV, and VSV and examined the expression of IL-27 and TNF. FOSL1-silenced cells increased TNF expression after IAV infection. Moreover, IL27 was increased in FOSL1-silenced monocytes after IAV and MV infection. These data suggest that RNA viruses that signal through TLR7 increase expression of FOSL1 to restrain type 1 proinflammatory cytokine production ( Fig. 7E ).
TLR7 signaling does not induce a type I IFN response in human CD14 + monocytes
An important function of myeloid cells is their capacity to promote an antiviral state after RNA virus infection by secreting type I IFN and expression of ISGs (65) . Monocytes infected with several RNA viruses secreted type I IFN in a TLR7-independent manner (Fig. 3) . To examine whether direct stimulation through TLR7 induced a type I IFN response, CD14 + monocytes were stimulated ex vivo with IMQ or ssRNA40 for 36 hours, and the expression of IFNA1, IFNA2, and IFNB1 was examined at various time points (Fig. 8A) . Although IMQ did not increase expression any of the three cytokines at any time point, ssRNA40 induced all three with different expression kinetics. These data were confirmed at protein level by measuring IFN and IFN in the culture supernatant (Fig. 8B) . The lack of IFN response after TLR7 stimulation was not due to the specific concentration of IMQ used, because none of the various concentrations tested within the recommended range induced significant expression of any of the IFN cytokines (Fig. 8C) , whereas increasing amounts of ssRNA40 increased the expression of IFNA1, IFNA2, and IFNB1 and secretion of IFN and IFN proteins (Fig. 8D) . Accordingly, the expression of ISGs was virtually absent in IMQ-stimulated monocytes, but TLR8 activation promoted the expression of all six ISG tested (Fig. 8E ). To confirm that the defect in IFN expression after IMQ stimulation was due to a specific inability of TLR7 triggering to induce IFN in monocytes, we stimulated monocytes with GDQ and Loxo as TLR7 ligands, and with ssRNADR and PolyU as TLR8-specific ligands, and IFN gene expression was examined 16 hours later (Fig. 8F) . Although neither GDQ nor Loxo induced IFN expression, both ssRNADR and PolyU statistically significantly increased the expression of IFNA1, IFNA2, and IFNB1. Pretreatment of monocytes with IRS661 and IRS957 confirmed the TLR8 specificity of the results obtained (Fig. 8G ). Induction of a type I IFN response in myeloid cells after nucleic acid-sensing TLR stimulation can involve the activation of TANKbinding kinase 1 (TBK1) by nucleic acid-sensing TLRs (66) . Subsequently, IRF3 and IRF7 are activated (67, 68) , and both are important for the expression of type I IFN genes (65) . We examined the activation of the TBK1-IRF3/7 pathway in monocytes stimulated with IMQ or ssRNA40 as compared to vehicle-treated cells (Fig. 8, H and I) . The activation of TBK1 was increased by ssRNA40 during the first 30 min of stimulation. In contrast, there was only a slight increase in the phosphorylation of TBK1 after IMQ stimulation at 15 min when compared to vehicle-treated monocytes. We then examined the phosphorylation of IRF3 by TBK1 at Ser 386 , and although both TLR7 and TLR8 stimulation induced IRF3 activation, phosphorylation of IRF3 by ssRNA40 was significantly stronger at each time point than that of IMQ-stimulated cells (Fig. 8I ). RNA viruses promoted phosphorylation of IRF3, and those that predominantly signaled through TLR7 instead of TLR8 (VSV, MV, and IAV) activated less pIRF3 in the presence of the TLR7 inhibitor IRS661. In contrast, EMCV-dependent pIRF3, which preferentially activates TLR8, was only reduced in the presence of the TLR8 inhibitor IRS957 but not IRS661. Furthermore, blocking both TLR7 and TLR8 did not completely abrogate pIRF3, in agreement with the involvement of other nucleic acid-sensing mechanisms during infection with the RNA viruses tested ( fig. S9 ).
Although recent data suggest that unlike TLR8, TLR7 signaling specifically induces activation of IRF5 over IRF3 (69), we did not observe preferential activation of IRF5 by TLR7 as compared to TLR8. These data are in agreement with the observation that TLR8 can also lead to the activation of IRF5 in human primary monocytes and macrophages (70) . These data suggest that differential activation of IRF5 is not responsible for the differences in type I IFN responses observed between TLR7 and TLR8 stimulation ( fig. S10 ).
TLR7-dependent Ca 2+ signaling inhibits type I IFN response
The increased IRF3 activation by IMQ did not correlate with the lack of IFN gene expression, suggesting that other mechanisms could be inhibiting the expression of type I IFN genes. We hypothesized that a TLR7-specific pathway triggered by IMQ would inhibit IFN expression. An important difference that we had previously observed between TLR7 and TLR8 signaling on CD4 + T cells was an increase in intracellular Ca 2+ triggered by TLR7 stimulation that did not occur after ssRNA40 stimulation (71) . Because Ca 2+ signaling alters the functions of myeloid cells, and it is an important modulator of cell responses during viral infections (72, 73) , we examined how TLR7 stimulation may alter intracellular Ca 2+ concentration in monocytes ( Fig. 9A ). Unlike ssRNA40, IMQ stimulation increased intracellular Ca 2+ concentration in a dose-dependent manner (Fig. 9A ). The effect observed was TLR7 dependent, because preincubation with IRS661 almost completely inhibited Ca 2+ flux as compared to IRS controltreated monocytes (Fig. 9B) . To determine the origin of the increase in Ca 2+ , we stimulated monocytes with IMQ in the presence of EGTA (extracellular Ca 2+ chelator) and xestopongin C, an inhibitor of inositol 1,4,5-triphosphate-dependent Ca 2+ release. Whereas chelation of extracellular Ca 2+ did not affect IMQ-induced increase in Ca 2+ , xestopongin C inhibited it almost completely, suggesting that TLR7-driven increased in intracellular Ca 2+ occurs through depletion of internal stores located in the endoplasmic reticulum (Fig. 9C) .
We hypothesized that TLR7-dependent Ca 2+ flux may inhibit the expression of type I IFN. To test this, we used Quin-2 AM as a chelating agent to block free intracellular Ca 2+ (71, 74) , and we stimulated monocytes with IMQ to examine the expression of type I IFN genes (Fig. 9, D and E) . Although Quin-2 AM alone had no statistically significant effect on the expression of any of the genes tested, stimulation of monocytes with IMQ in the presence of increasing concentrations of Quin-2 AM statistically significantly augmented the expression of IFNA1 and IFNA2. Accordingly, the expression of ISGs was also increased by IMQ when intracellular Ca 2+ flux was blocked (Fig. 9D) . The increased IFNA gene expression was confirmed at protein level by IFN in the culture supernatant ( Fig. 9F ). When we examined whether Ca 2+ blockade had an effect on IRF3 and IRF7 expression ( Fig. 9G ), we found that monocyte stimulation with IMQ in the presence of Quin-2 AM significantly increased the expression of IRF7 at 24 hours, but IRF3 expression was significantly decreased when compared to IMQ only-treated cells. These results were similar to the pattern of IRF3 and IRF7 expression observed after TLR8 stimulation as compared to vehicle-treated cells at similar time points ( fig. S11 ). Because increases in intracellular Ca 2+ concentration can activate nuclear factor of activated T cells (NFAT) (71), we preincubated monocytes with VIVIT peptide (75) , which inhibits NFAT activation by preventing its nuclear translocation, before IMQ stimulation. We found that the TLR7-dependent antagonistic effects on proinflammatory cytokine and type I IFN gene expression were NFAT independent, because VIVIT peptide did not restore the expression of IL12, IL27, and TNF nor the expression of type I IFN genes ( fig. S12 ). Together, these results suggest that TLR7-dependent Ca 2+ signaling acts as an inhibitor of type I IFN response in human CD14 + monocytes, independently of IRF3 and IRF7 expression, as well as NFAT activation.
TLR7-dependent FOSL1 expression is Ca 2+ and ERK dependent
To further explore how TLR7 stimulation increased the expression of FOSL1 (Fig. 7) , we pharmacologically inhibited pathways previously identified that were activated after TLR7 activation, including p38, ERK, JNK (Fig. 6 ), and Ca 2+ (Fig. 8) . We stimulated monocytes with IMQ in the presence of inhibitors of p38 (SB203580), ERK1/2 (SCH772984), JNK (SP600125), and the Ca 2+ intracellular chelator Quin-2 AM, and we measured FOSL1 expression ( Fig. 10) . Although p38 and JNK inhibition did not abrogate IMQ-stimulated FOSL1 expression, both ERK1/2 inhibition and Ca 2+ chelation with Quin-2 AM statistically significantly inhibited the expression of ( Fig. 10E ). FOSL1 silencing in monocytes did not restore IFNA expression after IMQ activation nor increase IFNA gene expression after ssRNA40 stimulation. Together, these data suggest that both TLR7-dependent ERK1/2 activity and Ca 2+ flux promote FOSL1 expression in human monocytes, but FOSL1 is not involved in the inhibition of type I IFN response after TLR7 stimulation.
DISCUSSION
The innate immune system is armed with receptors that sense pathogens to mount effective immune responses during infection. Monocytes are a major target of many viruses, and infection not only induces monocyte differentiation into other cell populations but it also activates them to perform effector functions (4) . In this work, we dissected the TLR7-and TLR8-dependent events that tune the activation of human monocytes upon RNA virus infection, and we defined TLR7-and TLR8-specific signaling pathways in this process ( fig.  S13 ). Furthermore, by dissecting the signaling pathway downstream TLR7, we found that FOSL1 inhibits the expression of type 1 cytokines upon TLR7 signaling. Last, we described the TLR7-Ca 2+ axis limited type I IFN responses in CD14 + monocytes.
While APCs in general use a variety of sensors to detect pathogens, initial virus sensing is carried out by RLRs leading to local IFN production (11) . Subsequently, both RLR and TLR act in concert to specifically tune the adaptive immune response (31) . Thus, whereas RLR signaling is essential for the initial triggering of antiviral responses, the TLR serve a secondary role to drive specific cytokine production and type I IFN responses to regulate and shape the type of adaptive immune response and programming of cell-mediated immunity (77, 78) . In this regard, we observed that monocyte infection with a variety of RNA viruses led to various phenotypes that were dependent on TLR7 and/or TLR8 signaling. However, and in agreement with the involvement of RLR in innate immune activation, TLR7 or TLR8 blockade upon virus infection did not completely abrogate the expression of cytokines in our experimental system (79, 80) . The concerted actions of these pathways to human monocyte function has not been addressed, and it will be interesting for future studies to examine the cross-talk between TLR7 and TLR8 signaling and other nucleic acid-sensing pathways in human monocytes during virus infection. Our data demonstrated that TLR7 and TLR8 signaling in CD14 + monocytes are significantly different, and although TLR7 preferentially increased expression of T H 17-polarizing cytokines through the activation of MAPK cascades that lead to AP-1 activation ( Fig. 7 and Fig. 10 ), TLR8 predominantly induced type 1 cytokines, which are NFB dependent (46) . TLR7 and TLR8 signaling have differential roles in other immune cell populations, such as DCs and neutrophils (70, (81) (82) (83) (84) , and TLR8 promotes preferential type 1 cytokine secretion when compared to TLR7 stimulation in natural killer cells (81) . Furthermore, in other disease settings, TLR7 inhibits type 1 cytokine secretion (85) , and TLR7 engagement on DCs leads to an activated phenotype with increase ability to promote T H 17 responses in an in vivo model of uveitis (86) and in human DC in vitro (87) . FOSL1 is expressed primarily in T H 17 cells as compared to other T helper subsets, and IL-17 is directly controlled by FOSL1 (88) . Moreover, FOSL1 expression is correlated with high psoriasis (89) and increased susceptibility to collagen-induced arthritis (88) . AP-1 family of transcription factors activate expression of genes involved in proliferation, activation, and other cell functions. The observation that FOSL1 inhibits type 1 proinflammatory cytokines underscores the complexity of the AP-1 family, which is generally overlooked, and raises the questions of whether individual stimuli activate specific AP-1 dimers, what the transcriptional targets for each dimer are, and what the distribution of AP-1 dimers across cells types or over time in a specific cell type are (54) . Furthermore, in agreement with our results, other AP-1 members inhibit TLR signaling (90, 91) . For example, loss of cFOS in mice results in increased NFB signaling in response to lipopolysaccharide (LPS) (92, 93) , and overexpression of FOSL1 in macrophages inhibits the expression of proinflammatory cytokines after LPS stimulation (94, 95) . Consistent with ERK activation by Ca 2+ in other cell systems (96, 97) , we observed that the TLR7-dependent increase in FOSL1 expression was dependent on both increased Ca 2+ concentrations and ERK activation. Therefore, it is plausible that these two events may occur sequentially after TLR7 activation to induce the expression of FOSL1, with TLR7-induced Ca 2+ increase activating ERK activity, which in turn is required for the up-regulation of FOSL1.
The observation that TLR7 ligation inhibits type I IFN response by augmenting intracellular Ca 2+ release in monocytes is unexpected, and further investigations are warranted to dissect the mechanisms by which calcium modulates type I IFN responses. However, several works have suggested a negative relationship between calcium signaling and IFN activity (98-100), and it is well known that viruses use diverse strategies to inhibit type I IFN responses (101) . It is thus tempting to speculate that RNA viruses would use TLR7 signaling when infecting CD14 + monocytes to avoid type I IFN responses and expand in the host, be transported to other tissues, etc. In support of our data, several signaling molecules that are involved in TLR7 signaling in human monocytes inhibit type I IFN responses in other cell types, such as MEK1/2-ERK (102) and FOSL1 (76) . Moreover, in human macrophages after hepatitis C virus infection (14) and in human DCs after influenza infection or small-molecule activation (103), TLR7 stimulation limits type I IFN expression.
The involvement of nucleic acid-sensing mechanisms in the immune response against infections and even in autoimmune diseases (104) makes these pathways interesting targets for drug design. TLR agonists are being tested in clinical trials in cancer and infectious diseases, because they provide enhanced immune responses in these settings (10, 105) . In this regard, our results have important consequences on the selection of these agonists as adjuvants in therapeutic immunizations against cancer or prophylactic vaccines against pathogens and demonstrate that the fundamental differences in signaling between these two related receptors could potentially be harnessed to tailor specific immune responses in various disease settings.
MATERIALS AND METHODS

Study subjects
Peripheral blood was drawn from healthy participants after informed consent and approval by the Institutional Review Board at Yale Uni-versity and Imperial College London. All experiments were performed conformed to the principles set out in the World Medical Association Declaration of Helsinki and the Department of Health and Human Services Belmont Report.
Cell culture reagents
Cells were cultured in RPMI 1640 media supplemented with 2 nM l-glutamine, 5 mM Hepes, penicillin/streptomycin (100 U/g per milliliter) (BioWhittaker), 0.5 mM sodium pyruvate, 0.05 mM nonessential amino acids (Life Technologies), and 5% human AB serum (Gemini Bio-Products). Monocytes were cultured in 96-well polypropylene plates to avoid nonspecific activation by adhesion to polystyrene.
The TLR7-specific inhibitory sequence IRS661, the TLR8-specific sequence IRS957, and an NT sequence as a control were synthesized by Sigma-Aldrich on a phosphorothioate backbone and used at 2 to 5 M. None of these inhibitory sequences induced statistically significant cell death at the concentrations described above. The p38 inhibitor SB203580 (Selleckchem) (106, 107) , the ERK1/2 inhibitor SCH772984 (Selleckchem) (108, 109) , and the JNK inhibitor SP600125 (InvivoGen) (110, 111) were used at 2 and 10 M. The Ca 2+ chelator Quin 2-AM (Thermo Fisher Scientific) was used at 0.5 and 2.5 M (71).
Cell isolation and activation with TLR ligands
Peripheral blood mononuclear cells were isolated from healthy donors by Ficoll-Paque PLUS gradient centrifugation (GE Healthcare). Classical CD14 + monocytes were isolated by positive selection using the EasySep Human CD14-Positive Selection Kit (STEMCELL Technologies). Total CD4 + T cells were isolated by negative selection using the EasySep Human CD4 + T cell Enrichment Kit (STEMCELL Technologies). B cell isolation was performed with the EasySep Human CD19 Positive Selection Kit II (STEMCELL Technologies). The following TLR ligands were used to stimulate CD14 + monocytes: IMQ, in concentrations ranging from 0.1 to 10 g/ml, ssRNA40-LyoVec (InvivoGen), in concentrations ranging from 0.1 to 5 g/ml, 0.5 mM Loxo, GDQ (2.5 g/ml), ssRNA-DR (2.5 g/ml), and PolyU (2.5 g/ml). All TLR ligands (<0.001 EU/g; EndoFit) were obtained from InvivoGen and resuspended in endotoxin-free water according to the manufacturer's recommendations.
Monocyte-RNA virus cocultures
CD14 + monocytes were stimulated with RNA viruses at a multiplicity of infection (MOI) of 5 for 16 hours at 37°C. The viruses used in this manuscript are CV B1 (Conn-5 strain), MV (Edmonton strain), SV (Sendai/52 strain), EMCV, all obtained from the American Type Culture Collection. VSV (Indiana strain) was a gift from A. Iwasaki's laboratory (Department of Immunobiology, Yale School of Medicine), and IAV (PR8 strain) was a gift from A. Garcia-Sastre's laboratory (Icahn School of Medicine, Mount Sinai, NY). Culture supernatant was collected for cytokine release measurement by ELISA, and cells were lysed in RLT Plus buffer (QIAGEN) for gene expression assays.
CD14 + :CD4 + T cell cocultures
Freshly isolated CD14 + monocytes were resuspended at 10 6 cells/ml in complete medium and stimulated with IMQ (2.5 g/ml), ssRNA40 (2.5 g/ml), or vehicle for 16 hours at 37°C. Subsequently, monocytes were cocultured with isolated CD4 + T cells from the same donor in the presence of anti-CD3 (1 g/ml; UCHT1 clone, BD Biosciences) at different T cell:monocyte ratios. Supernatant was collected after 24, 72, and 120 hours for IFN and IL-17 measurement by ELISA, and the cells were stained with LIVE/DEAD fixable violet dye (Thermo Fisher Scientific), CD14 and CD3. CD3 + CD14 -T cells were sorted on a FACSAria (BD Biosciences) and lysed with RLT Plus buffer (QIAGEN) to examine gene expression by real-time PCR.
Enzyme-linked immunosorbent assay IL-1, IL-6, IL-12, IL-27, and TNF were measured from supernatants of stimulated monocyte cultures, and IL-17 and IFN from supernatants of monocyte:CD4 + T cell coculture experiments with Human DuoSet ELISA Kits from R&D Systems, according to the manufacturer's recommendations. IFN and IFN were measured from stimulated monocyte cultures using the VeriKine Human ELISA kits for IFN and IFN, respectively (PBL Assay Science), using the manufacturer's recommendations.
Quantification of mRNA expression levels by real-time PCR
RNA was isolated using the QIAGEN RNeasy Micro Kit (QIAGEN) or the ZR-96 Quick RNA (Zymo Research, Irvine, CA) following manufacturer′s guidelines and converted to complementary DNA by reverse transcription (RT) with random hexamers and Multiscribe RT (TaqMan Reverse Transcription Reagents; Thermo Fisher Scientific). For mRNA gene expression assays, probes were obtained from Thermo Fisher Scientific, and the reactions were set up following the manufacturer's guidelines and run on a StepOnePlus Real-Time PCR System (Thermo Fisher Scientific). Values are represented as the difference in cycle threshold (Ct) values normalized to 2microglobulin for each sample as per the following formula: Relative RNA expression = (2 -Ct ) × 1000. Gene expression data were arranged in heat maps in Fig. 1 to identify virus-specific cytokine expression patterns. Colors are assigned using linear conditional formatting based on relative expression values of each gene for each donor and virus infection as compared to the expression value of that gene for all other donors and virus infections. Red denotes high expression and blue low expression.
For mRNA expression assays, the following probes were used:
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